阿尔茨海默氏症连续性的神经病理学:一个更新
1Institute of Clinical Neurobiology, Vienna, Austria.
Free neuropathology
|June 7, 2023
概括
阿尔茨海默病 (AD) 涉及复杂的蛋白质问题,如粉样蛋白和. 了解其各种病理是改善诊断和治疗成功的关键.
科学领域:
- 神经病理学神经病理学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,其特点是混合蛋白质病变,主要是粉样蛋白和粉样蛋白.
- 阿尔茨海默病现在被视为一个连续体,具有多种不同的病理亚型和区域性tau模式.
- 病理学特征包括粉样斑块,神经纤维状结和神经炎症,以及其他与年龄相关的变化.
研究的目的:
- 为提供有关阿尔茨海默病神经病理学的最新概述.
- 突出阿尔茨海默病的异质性和共同病理的影响.
- 解释AD的诊断挑战和临床试验失败.
主要方法:
- 关于阿尔茨海默病神经病理学的当前文献的综述.
- 对AD亚型和相关病理学的分析.
- 对诊断和治疗障碍的讨论.
主要成果:
- 阿尔茨海默病是一种异质性疾病,具有不同的亚型,影响临床表现.
- 像Lewy体和TDP-43蛋白质病变这样的共同病理在AD中很常见.
- 阿尔茨海默病神经病理学的复杂性使诊断和治疗策略变得复杂.
结论:
- 了解AD的异质性和共同病理对于准确诊断至关重要.
- 阿尔茨海默病的多因素性质有助于开发有效治疗的挑战.
- 需要对AD的潜在病因和病理值进行进一步的研究.
相关概念视频
Alzheimer's Disease: Overview
536
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
536
Alzheimer's Disease: Treatment
224
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
224
Dementia
143
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
143
Parkinson's Disease: Overview
612
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
612
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K


